TNPSC Thervupettagam

Abdala vaccine

June 26 , 2021 1161 days 697 0
  • Cuba said that its Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials.
  • It is a three-shot vaccine.
  • It is developed by the Centre for Genetic Engineering and Biotechnology in Cuba.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories